In short. Psoriasis is more than plaques. How the diagnosis is confirmed, what the associated conditions mean for screening, and how the treatment ladder is chosen.
Key points
- Limited disease is treated with topical therapy and, where suitable, targeted phototherapy.
- Widespread or stubborn disease moves to conventional systemic therapy, then to biologic or small-molecule treatment when control is still inadequate.
- Stepping up is not a failure of willpower or of the previous treatment — it reflects disease severity.
Psoriasis is a chronic immune-mediated inflammatory disease that appears mainly on the skin but is not confined to it. Well-defined red plaques with silvery scale on the elbows, knees, scalp, and lower back are the classic picture, but the disease also affects nails, joints, and — through low-grade systemic inflammation — the wider body. Understanding that it is systemic rather than cosmetic is central to treating it well.
How the diagnosis is made
Most psoriasis is diagnosed clinically. The distribution, the sharp border of the plaques, and the way scale lifts to reveal pinpoint bleeding points are characteristic. Nail changes — pitting, ridging, separation, and discolouration — support the diagnosis, and scalp involvement is common and often mistaken for severe dandruff. When the picture is atypical, a skin biopsy confirms the pattern and excludes eczema, fungal infection, and cutaneous lymphoma. Severity is recorded by the proportion of body surface involved and by standard scoring instruments, so that treatment response is measured objectively rather than by impression.
What a hospital assessment adds
Because psoriasis is associated with other conditions, assessment extends beyond the skin. Joint symptoms are asked about specifically, since a substantial proportion of people develop psoriatic arthritis and early treatment protects joints. Weight, blood pressure, blood sugar, and lipids are reviewed, because the association with metabolic and cardiovascular disease is well established. Before systemic or biologic treatment is started, screening for tuberculosis and viral hepatitis and baseline blood tests are required, and these are performed as part of the treatment plan rather than as an afterthought.
Treatment is staged, and stepping up is normal
Limited disease is treated with topical therapy and, where suitable, targeted phototherapy. Widespread or stubborn disease moves to conventional systemic therapy, then to biologic or small-molecule treatment when control is still inadequate. Stepping up is not a failure of willpower or of the previous treatment — it reflects disease severity. Many people need long-term treatment, and stopping effective therapy to “give the body a rest” usually brings the disease straight back.
Treatment classes
Topical treatments include corticosteroid preparations, vitamin D analogue preparations, and combined formulations used for plaques and scalp disease. Phototherapy uses controlled ultraviolet exposure under supervision. Systemic options include conventional immunosuppressive and anti-inflammatory agents, and the targeted biologic and small-molecule treatments that act on specific steps in the inflammatory pathway. Choice depends on severity, sites involved, joint disease, other medical conditions, and monitoring requirements.
Follow-up and honest limits
Psoriasis cannot be cured and it fluctuates. Good follow-up reviews skin control, joint symptoms, cardiovascular risk factors, and the safety of long-term treatment. Triggers such as stress, infection, certain medicines, and alcohol are worth knowing. With modern treatment most people achieve substantial clearance, but relapses occur and the disease requires ongoing management rather than a single course.
Seek review promptly if
- The rash becomes widespread and the skin is hot, painful, or shedding in sheets, or you develop fever — this can be a severe form of psoriasis needing hospital care.
- Pustules appear on reddened skin, with fever or a feeling of being unwell — urgent assessment and treatment are required.
- Joints are painful, swollen, or stiff, especially in the morning or in the fingers, heels, or spine — early treatment of joint disease prevents lasting damage.
Frequently asked questions
Why is psoriasis described as a systemic disease?
Because it is not confined to the skin. It is associated with psoriatic arthritis, and with metabolic and cardiovascular disease, so assessment covers joints, weight, blood pressure, blood sugar, and lipids, not only the plaques. Treatment is staged accordingly.
Is stepping up psoriasis treatment a sign of failure?
No. Moving from topical therapy to phototherapy, conventional systemic therapy, or biologic treatment reflects disease severity rather than willpower. Stopping effective therapy to give the body a rest usually brings the disease straight back, so long-term treatment is normal.
What screening is needed before systemic psoriasis treatment?
Screening for tuberculosis and viral hepatitis, plus baseline blood tests, is required before systemic or biologic treatment begins. These are performed as part of the treatment plan rather than as an afterthought, and monitoring continues while treatment is given.
Risks & Limitations
- Most chronic skin disease is managed rather than cured, and relapse is expected.
- Treatments typically need 8–12 weeks before response can be judged fairly.
- Topical treatment can cause irritation, dryness, peeling and photosensitivity.
- Systemic therapy may require blood monitoring and carries organ, metabolic and pregnancy risks.
- Isotretinoin in particular requires strict monitoring and pregnancy prevention.
- Pigment change is often slow and may be incomplete.
- No treatment works for everyone, and response cannot be predicted with certainty.
When to Seek Care
- A mole or lesion that changes in size, shape or colour, or starts to bleed, itch or crust.
- Fever with a widespread rash, blistering, or rash involving the eyes, mouth or genitals — seek emergency care.
- Rapidly spreading redness, swelling or pain in the skin.
- Facial swelling or difficulty breathing — possible severe reaction; seek emergency care immediately.
- New or worsening symptoms while taking a monitored medication.
References & Further Reading
- American Academy of Dermatology (AAD) — public and clinical guidance
- World Health Organization (WHO) — skin and infectious disease resources
- Chinese Medical Association, Dermatology Branch — clinical guidance
- Cochrane Library — systematic reviews in dermatology
This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.